Monocytes have a crucial role in both proinflammatory and anti-inflammatory phenomena occurring during sepsis. Monocyte recruitment and activation are orchestrated by the chemokine receptors CX3CR1 and CCR2 and their cognate ligands. However, little is known about the roles of these cells and chemokines during the acute phase of inflammation in sepsis. Using intravital microscopy in a murine model of polymicrobial sepsis, we showed that inflammatory Ly6C high monocytes infiltrated kidneys, exhibited altered motility, and adhered strongly to the renal vascular wall in a chemokine receptor CX3CR1-dependent manner. Adoptive transfer of Cx3cr1-proficient monocyte-enriched bone marrow cells into septic Cx3cr1-depleted mice prevented kidney damage and promoted mouse survival. Modulation of CX3CR1 activation in septic mice controlled monocyte adhesion, regulated proinflammatory and anti-inflammatory cytokine expression, and was associated with the extent of kidney lesions such that the number of lesions decreased when CX3CR1 activity increased. Consistent with these results, the pro-adhesive I249 CX3CR1 allele in humans was associated with a lower incidence of AKI in patients with sepsis. These data show that inflammatory monocytes have a protective effect during sepsis via a CX3CR1-dependent adhesion mechanism. This receptor might be a new therapeutic target for kidney injury during sepsis.
endothelium. 11 Recent studies have called attention to the dual role of inflammatory monocytes in acute inflammation and especially infection. They protect tissues during infectious processes, such as pneumonia or gastrointestinal toxoplasmosis, notably via their secretion of IL-1 receptor antagonist 9, 12, 13 (IL-1ra) or prostaglandin E2. 8 Essential crosstalk among monocytes, neutrophils, and tissue (especially epithelial cells) controls the equilibrium between inflammatory and anti-inflammatory processes.
CX3CR1, the receptor of CX3CL1, may be involved in the pathophysiology of sepsis. Kidneys are subject to insult during septic episodes; AKI is a common feature of sepsis and is associated with increased mortality. AKI results, in part, from leukocyte infiltration of kidney tissue and the generation of proinflammatory and proapoptotic mediators. 14, 15 Studies have shown that sepsis is associated with monocyte infiltration of the kidneys 14 and with increased levels of CX3CL1 in situ. 16 Here, we show that during polymicrobial sepsis, inflammatory monocytes emigrated from the bone marrow and induced monocytosis accompanied within a few hours by enhanced CX3CR1-dependent adhesion to the renal cortex endothelium. CX3CR1 deficiency increased renal damage and mouse mortality and was correlated with reduced monocyte margination. We further confirmed that the CX3CR1 conferred protective functions linked to inflammatory monocyte adhesiveness and reduced production of IL-1ra in Ly6C high monocytes. The involvement of CX3CR1 in the physiopathology of sepsis was confirmed in humans, through a CX3CR1 gene polymorphism study that showed that the I249 CX3CR1 allele is associated with both increased monocyte adhesiveness and reduced kidney damage. Our work describes the protection conferred by inflammatory monocytes against the distant kidney damage caused by septic inflammation.
RESULTS

Ly6C high Monocytes Exhibit Increased Adhesion to the Renal Endothelium during Sepsis
To determine the role of monocytes in kidneydamage during sepsis, we used a standard murine model of abdominal sepsis induced by cecal ligation and puncture (CLP). 17 In our experimental conditions, 50% of the mice died of sepsis in 4 days (Supplemental Figure 1A ). Six hours after sepsis induction, the number of CD11b Figure 1B) . Twenty-four hours after CLP, the number of Ly6C high monocytes reverted to that in the sham (control) group. The kinetics of mobilization in the blood and infiltration into the kidneys was the same for neutrophils as for Ly6C high monocytes (Supplemental Figure 1B) . To examine the functional role of monocytes, we performed multiphoton intravital imaging on kidneys from sham-and CLPoperated MacBlue3Cx3cr1 gfp/+ mice. In the MacBlue mouse, 20 all blood monocytes are strongly positive for enhanced cyan fluorescent protein (ECFP), whereas most tissue macrophages do not express the reporter protein. 21 In contrast, renal DCs are CX3CR1 + and strongly express the green fluorescent protein (GFP) reporter. 22 Figure 1C ). Time-lapse imaging of the kidneys of the shamoperated mice showed that numerous ECFP + cells traveled through the cortex in the bloodstream, interacting very little with the endothelium, while the activity of renal DCs was strongly protrusive (Supplemental Movie 1). At 6 hours after CLP, renal DC behavior did not change, but the number of ECFP + cells adhering to the luminal side of the vessel increased (Supplemental Movie 2). We defined three motility patterns of ECFP + cells: circulating, crawling, and adhering ( Figure 1D ). Six hours after CLP, the proportion of circulating ECFP + cells had fallen by .50%, while the proportion of crawling and adhering ECFP + cells had increased above the levels in the sham-operated mice ( Figure 1E ). Mean dwell time and mean contact duration quadrupled ( Figure 1F ). Contact duration increased for ECFP + , but they were mainly released without any evidence of extravasation toward the kidney tissue.
Intravital imaging on CLP-operated MacBlue3Cx3cr1 Figure  1G ). Overall, CLP strongly modified the signature of ECFP + cells compared with that of sham-operated mice. Adhesion of the ECFP + cells increased after CLP, and their track straightness declined, as did their mean velocity. At the same time, their arrest coefficient, dwell time, and contact duration with the endothelium all increased ( Figure 1G ).
These findings show that within a few hours after CLP, the number of Ly6C high monocytes in the blood increased and they interacted with the renal endothelium.
CX3CR1 Promotes Ly6C
high Monocyte Adhesion and Prevents Renal Damage during Sepsis Previous reports have shown that CX3CR1 deficiency is associated with increased mortality after CLP, 24 but the precise mechanisms involved have not been adequately defined. We sought to determine the role of CX3CR1 in the pathogenesis of organ damage during sepsis. Cx3cr1 2/2 mice had conspicuously more kidney histologic lesions than WT mice ( Figure 2A ). The proportion of damaged tubules during CLP was two times higher in the Cx3cr1 2/2 mice ( Figure 2B ), which also had substantially higher levels of markers of renal failure, such as creatinemia and uremia ( Figure 2C ). The kidney was not the only affected organ, but renal damages were associated with increased mortality after CLP (Supplemental Figure 3A) . To determine whether this phenotype could be due to impaired bactericidal activity, as suggested, 25 we compared mice survival in a sterile inflammation model, by injecting mice with a lethal dose of LPS. The strong reduction in survival of Cx3cr1 2/2 mice suggests that the phenotype observed was independent of control of the bacterial burden and emphasizes the relationship with organ damage (Supplemental Figure 3B) . On the other hand, and as others have recently reported, 26 these two types of mice did not differ in the number of Ly6C high monocytes ( Figure   2D ) or neutrophils (not shown) in bone marrow, kidneys, or blood. This prompted us to perform functional imaging to compare dynamic behavior of Ly6C high monocytes from CX3CR1-deficient and WT mice during sepsis.
Thus, we used MacBlue3Cx3cr1 gfp/gfp mice 6 hours after CLP ( Figure 2E ). In the absence of CX3CR1, the proportion of adhering and crawling ECFP + cells fell ( Figure 2F ), as did ECFP + cell dwell time and contact duration ( Figure 2G ). The radar chart representation of the motility pattern showed distinct cell dynamic signature between septic MacBlue3Cx3cr1 gfp/+ and septic MacBlue3Cx3cr1 gfp/gfp mice ( Figure 2H ). This loss of adhesion was specific to ECFP + cells: Neutrophil behavior did not differ between the two strains (Supplemental Figure 3 , C-E). To further address that the reduced adherence is intrinsic to the CX3CR1 deficiency, Cx3cr1 2/2 and Cx3cr1 +/+ ECFP + cells were transferred into septic WT mice and the proportion that adhered to the renal vascular wall was determined (Supplemental Figure 3F ). Accordingly, Cx3cr1 2/2 ECFP + cells adherence was much weaker than that of Cx3cr1 +/+ ECFP + cells. We conclude that the CX3CR1 receptor is functionally important during sepsis; its absence leads to reduced inflammatory monocyte adhesion to the renal vascular wall, more numerous kidney lesions, and increased mortality. This observation suggests that inflammatory monocytes have a potent unexpected protective effect during sepsis.
Bone Marrow-Derived Monocytes Protect against Damage to Kidney Tissue during Sepsis
To examine the protective role circulating Ly6C high monocytes may play, we first performed CLP in Ccr2 2/2 mice that display a Ly6C high monocytopenia (Supplemental Figure 2A) . Consistent with our hypothesis, the number of kidney lesions was dramatically higher in Ccr2 2/2 than in WT mice ( Figure 3A ). It has also been reported that phagocyte are renoprotective during sepsis and that Cx3cr1 2 /2 mice have a defect in renal DC Number of Ly6C high monocytes in bone marrow, blood, and kidney of WT (blue) and Cx3cr1 2/2 (red) mice. Bars represent mean6SD (n=10 number. 26, 27 The number of renal DCs in Ccr2 2/2 mice was not impaired compared with the number in WT mice, confirming that the presence of renal DCs was not sufficient to protect from renal lesion (Supplemental Figure 2B ).
Adoptive transfers of CCR2-proficient monocyte-enriched bone marrow cells (MBMs) into Ccr2 2/2 mice drastically reduced kidney lesions during sepsis and thus further confirmed their protective effect (Figure 3A) . Finally, adoptive transfer of Cx3cr1-proficient MBM into septic Cx3cr1 2/2 mice provided significant protection against mortality ( Figure 3B ) and resulted in a diminution in kidney lesions to a level similar to that of WT mice ( Figure 3C ), compared with the transfer of Cx3cr1-deficient MBMs. These observations confirm that bone marrowderived monocytes have a protective role in organ damage during sepsis via a CX3CR1-dependent mechanism.
CX3CR1 Activation Controls Ly6C
high Monocyte Adherence and Outcome of CLP-Mediated Sepsis In further considering the role of CX3CR1-dependent adhesion of Ly6C high monocytes during sepsis, we treated septic mice with the CX3CR1 ligand (CX3CL1) or the antagonist (F1) of CX3CR1 that we have previously shown to inhibit monocyte adhesion to CX3CL1. 28 The proportion of adherent monocytes increased in the presence of the agonist and diminished in the presence of the antagonist (Figure 4, A and B) . In addition, dwell time and contact duration of monocytes increased after treatment with CX3CL1 and decreased after treatment with F1 ( Figure 4C ). The cell dynamic signature was inversely affected by treatment with CX3CL1 and F1 compared with control CLP-operated mice ( Figure 4D ). These different signatures were associated with a different level of organ failure. In particular, injection of the antagonist, F1, led to increased lesions ( Figure 4E ) and mortality (data not shown) without altering renal DC numbers (Supplemental Figure 2B ). In contrast, CX3CL1 injection diminished the number of kidney lesions ( Figure 4E ). These findings show that pharmacologic modulation of CX3CR1 activation strongly correlates with Ly6C high monocyte margination and kidney damage, thereby demonstrating CX3CR1 as a potential therapeutic target.
CX3CR1 Blockade Increases Kidney Inflammation and
Reduces IL-1ra Production by Ly6C high Monocyte during Sepsis To further investigate the molecular mechanism involved in protective effect by Ly6C high monocytes, we measured by flow cytometry the intracellular production of IL-1ra that was previously shown to attenuate lung injury after LPS treatment 9 ( Figure  5A ). IL-1ra mean fluorescence intensities were nearly doubled in Ly6C high monocytes 6 hours after CLP compared with shamoperated mice. F1 treatment efficiently reduced IL-1ra mean fluorescence intensities in Ly6C high monocytes ( Figure 5B ) and leads to increased TNF-a ( Figure 5C ), decreased TGF-b ( Figure  5D ), and IL1ra ( Figure 5E ) transcripts in the whole kidney 6 hours after CLP. In conclusion, CX3CR1 blockade is associated with reduced production of IL-1ra by monocytes and with a higher proinflammatory environment in the kidney.
The Proadhesive CX3CR1 I249 Allele Is Associated with a Reduced Incidence of AKI in Septic Patients
To evaluate whether the mechanism we described in this murine model might be relevant to the pathophysiology of human disease, we studied the effect of a frequent CX3CR1 polymorphism, I249. This polymorphism was shown to increase monocyte adhesion to CX3CL1 and could modulate the course of coronary artery disease, atherosclerosis, age-related macular degeneration, glioblastoma, or obesity. [29] [30] [31] [32] [33] We tested the effects of this polymorphism in vitro in cell adhesion assays and in a cohort of patient admitted to intensive care for sepsis. PBMCs from individuals with CX3CR1 VV genotype or VI genotype were assayed for adhesion ( Figure 6 , A and B). PBMCs from donors heterozygous for the I249 allele adhere significantly more than those homozygous for V249 allele, confirming our previous results. 34 We then studied the effect of the I249 allele on the occurrence of AKI in a cohort of patients with sepsis. This study included 239 patients without chronic renal failure. In most cases, sepsis origins were in primary or secondary peritonitis and respiratory tract infections, with no difference between groups. At least one I249 allele was present in nearly 50% of the patients, with a distribution of the VV, VI, and II genotype of 52%, 41%, and 6%, respectively. The I249 allele (VI or II genotypes) was associated with a lower incidence of AKI (Figure 6C) , with no differences between the groups in terms of age, disease severity, or comorbidities. Patients carrying the I249 allele had fewer coagulation disorders but the same rate of circulatory or respiratory failures and the same 28-day mortality (Supplemental Table 1 ). In the multivariate analysis, CX3CR1 was still significantly associated with a reduced occurrence of AKI after adjustment for age, Simplified Acute Physiology Score II, IL-6 levels, and number of comorbidities. The odds ratio for AKI in a patient with the I249 allele was 0.43 (95% confidence interval, 0.27 to 0.93) ( Table 1) . Thus, we showed that the I249 allele of CX3CR1 is associated with reduced AKI incidence in septic patients.
DISCUSSION
Inflammatory monocytes play crucial roles during sepsis through cytokine secretion and direct cell contact. 5, [35] [36] [37] Recent studies have identified a regulatory protective role for inflammatory monocytes in infectious diseases as they synthetize and secrete anti-inflammatory mediators, such as IL-1ra and prostaglandin E2. 8, 9 However, the specific contribution of inflammatory monocytes to the regulation of inflammation in early phases of sepsis remains unclear. Our results have unveiled a key role these monocytes play in renal tissue protection via a CX3CR1-dependent adhesion of inflammatory monocytes to the renal vascular endothelium. Previous studies have shown that inflammatory monocytes are involved in controlling inflammation in gram-negative pneumonia and abdominal infections. 8, 9, [38] [39] [40] [41] [42] A lower number of inflammatory monocytes has been associated with increased lesions in the lung and in the intestinal lamina propria. 8, 9, 38, 41 Other studies have shown that the CX3CR1/ CX3CL1 axis is involved in the pathogenesis of sepsis. Genetic disruption of the Cx3cr1 gene has been associated with increased mortality without any effect on neutrophil or monocyte recruitment. 24 In that study, the indirect interaction of monocytes with neutrophils reduced the ability of Cx3cr1 2/2 mice to eradicate bacteria. Recent findings by Hochheiser et al. 26 showed that CX3CR1 deficiency was associated with a reduced entry of DC precursors in the inflamed kidney. Additionally, this work showed that in a model of infectious GN, the absence of CX3CR1 was not associated with an increased bacterial burden in the kidney. 26 Antibacterial role associated with Cx3cr1 was unlikely to be the main role for this gene during sepsis. Indeed, we showed that mortality increased in Cx3cr1 2/2 mice subjected to sterile lethal inflammation induced by LPS injection. Regarding our result during CLP, the reduced number ANOVA t test was used; *P,0.05; ***P,0.001). Kidneys from CLP-operated mice treated with PBS (control) or F1 were extracted 6 hours after CLP and were evaluated by quantitative PCR for (C) TNF-a production, (D) TGF-b production, and (E) IL1ra production.
Results are represented as fold increase of CLP-operated mice (n=6 in each groups from two independent experiments; t test was performed; P value are indicated). and 95% confidence intervals of the estimate are presented).
of renal DCs in Cx3cr12/2 mice is unlikely the only cause of the adverse phenotype because in both bone marrow-derived celladoptive transfer that rescued CX3CR1-deficient mice from renal lesions and treatment of the antagonist F1 that mimicked the knockout phenotype in WT mice, renal DC numbers were unchanged.
Carlin et al. 43 showed that Ly6C low monocytes were specifically retained by inflamed capillaries in a G ai-and Toll-like receptor (TLR)-7-dependent manner and cleared dead cells. In accordance with our results, they observed that TLR4 activation by LPS painting did not induce any recruitment of Ly6C low monocytes. Thus, these data could delineate a specific role of Ly6C low monocytes during viral infections (while Ly6C high would be more recruited in bacterial infections) or a specific biphasic response with a first wave of Ly6C high monocytes recruited in a TLR4-dependent manner followed by a second wave of Ly6C low monocytes that will clear the vessels from dead cells.
Both Cx3cr1 gene deletion and pharmacologic inhibition of CX3CR1 led to enhanced renal damage and reduced survival, whereas treatment by the chemokine agonist CX3CL1 prevented kidney damage. In addition, adoptive transfer of Cx3cr1 2/2 monocytes confirmed that reduced adherence is due to CX3CR1 expression by monocytes. The CX3CR1 receptor is involved in monocyte adhesion to the vascular wall via various mechanisms; the first is direct binding of CX3CR1 to the membrane-anchored form of CX3CL1 44 and the other is an integrin-mediated adhesion. Treatments with Inflammatory agents such as LPS, TNF-a or IL-1 induce CX3CL1 overexpression by endothelial cells. 45 During sepsis, levels of soluble CX3CL1 also increase within 6 hours after sepsis onset and peak by 24 hours. 24, 46 The activation of CX3CR1 promotes the integrindependent adhesion mechanisms that are responsible for cell adhesion. 47, 48 Indeed, during sepsis the integrins cd11a and cd11b are involved in leukocyte adhesion to the pulmonary vascular wall. 49 We showed here that CX3CR1 is a major determinant of this phenomenon and that CX3CR1 deficiency reduces the adhesive properties of Ly6C high monocytes. The result that CX3CR1 play a protective role during sepsis is consistent with previous work 24, 46 showing that the administration of CX3CL1 can improve inflammatory response during sepsis and even reduce mortality. 24, 46 We did not observe improved survival, but we did observe reduced kidney lesions. Some of the anti-inflammatory functions of monocytes are closely related to their endothelial adhesion. The anti-inflammatory properties that IL-10 can exert on monocytes appear to occur only when these cells are adhesive. 50 Furthermore, integrin signaling is also responsible for increased expression of the IL-1ra gene. 51 Consistently, we have shown that CX3CR1 blockade led to reduced intracellular IL-1ra content in Ly6C high monocytes. This may explain how a deficiency in the CX3CR1 receptor could increase mortality and/or kidney lesions in mice and how the CX3CR1 I249 allele might reduce the incidence of AKI in septic patients. The I249 allele was also associated with a lower incidence of coagulation disorders during sepsis. This is consistent with a more pronounced endothelium protective effect of the monocytes carrying the rare allele. This observation could also participate in the reduction of AKI by diminishing the rate of microvascular dysfunction and clots that could account for AKI. 52 We observed no difference in patients' mortality at day 28. This could be due to an insufficient number of patients to observe an effect or to possible other effects of CX3CR1 polymorphism that we could not investigate in this study. CX3CL1 might therefore be proposed as a new therapeutic agent to prevent or to cure AKI in patients with sepsis.
In summary, our data delineated a CX3CR1-dependent renoprotective role played by Ly6C high monocytes during the early phase of sepsis.
CONCISE METHODS
Experimental details are provided in the Supplemental Material.
Mice
Male C57BL/6 mice were purchased from Elevage Janvier (Saint Isle, France All experiments and protocols were approved by the local animal experimentation ethics committee.
Human Polymorphism Study
We retrospectively studied DNA from patients included in previous studies. 55 Patients meeting the criteria for severe sepsis/septic shock and who had at least two organ failures defined by the Sepsis-related Organ Failure Assessment 25 were included. Patients with chronic renal failure were excluded. The Cx3cr1 V249I polymorphism (rs3732379) was detected as previously described. 32 The AP-HP Cochin Hospital Ethics Committee approved the study. The patient or the patient's next-ofkin provided written informed consent.
Polymicrobial Sepsis Induction
Polymicrobial sepsis was generated after a CLP procedure as described using a 21-gauge needle. 24 In the control animals, the cecum was exteriorized and reinserted in the abdomen. For some experiments, 3 mg of fractalkine (full-length fractalkine/CX3CL1; R&D Systems) was injected 
LPS Injection
LPS (Escherichia coli O111:B4) was injected at a dose of 15 mg/kg intraperitoneally.
Histologic Analysis
Quantification was performed on periodic acid-Schiff-stained, 3-to 5-mm kidney sections and on at least three mice per condition. For each mouse, the percentage of damaged tubules was calculated on three to five different randomly chosen fields comprising 200-300 tubules.
Flow Cytometry
Cell staining for flow cytometry and antibodies used are described in the Supplemental Material. Flow cytometry was performed with the FACScanto (BD Biosciences) flow cytometer. Analysis was performed with FlowJo software (TreeStar, Inc.).
Adoptive Transfer Experiments
Bone marrow cells were isolated from MacBlue-Cx3cr1 gfp/+ and MacBlue-Cx3cr1 gfp/gfp mice; cells were co-transferred at a 1:1 ratio 30 minutes before the CLP procedure. Analyses were done 6 hours after CLP. Bone marrow monocytes were extracted after negative selection removal of other cell types (see Supplemental Material). Before sorting, Ly6Chi monocytes represented nearly 16% of myeloid cells and were enriched to nearly 60% after sorting, while the neutrophils population was drastically reduced. In all experimental conditions, mice were injected with 4-5310 6 monocytes just before the CLP procedure.
Multiphoton Imaging
Mice were anesthetized with isoflurane. Their temperatures were maintained at 37°C. An incision was made in the flank, and the kidney was exposed. In some experiments, 2310 6 molecular weight tetramethylrhodamine-dextran (Invitrogen) was injected to stain the vasculature. Cell motility was measured every 30 seconds. Cells were tracked for 30 minutes with three-dimensional automatic tracking and manual correction with Imaris software. Definition of cells behavior and additional details are provided in the Supplemental Material.
Statistical Analyses
Data are reported as mean6SD or mean6SEM +/2 SD/SEM as indicated.
Groups were compared using a two-tailed unpaired t test and adjusted for multiple comparison analysis. Nonparametric Mann-Whitney test or ANOVA with adjustments was performed according to Gaussian distribution of each sample. Survival curves were compared using a log-rank test. Multivariate analysis of the human cohort was performed with JMP (SAS Institute, Inc., Cary, NC).
